The Bubs Australia Ltd (ASX: BUB) share price is slipping today despite no news having been released by the company.

Right now, the Bubs share price is 42 cents, 1.19% lower than its previous close.

Today’s dip marks the most recent of Bubs’ ASX woes. The Bubs share price has now fallen 17% in a month.

Let’s take a look at what’s been weighing on Bubs’ shares lately.

The month that’s been for Bubs

Bubs has only released a single piece of price-sensitive news to the market over the past month.

That news came in the form of a trading update, to which the Bubs share price reacted poorly.

The update stated the company’s financial year 2021 gross revenue was $46.8 million – 24% lower than the previous financial year.

However, its revenue over the fourth quarter was 8% higher than that of the third quarter. Additionally, the second half brought 10% more revenue than the first half did. Yet they both saw less revenue than their respective previous comparable periods.

The company stated the revenue slump was due to COVID-19.

Bubs has been hit particularly hard throughout the pandemic, largely due to the impact it’s had on daigou channels.

It wasn’t all bad news though. The company announced it has shipped the first batch of its Aussie Bubs formula to its new US retailers. The formula is destined to be stocked by Amazon.com and Walmart‘s online store next month.

Bubs also reported it had $27.9 million in cash reserves – enough to fund its operations for another 11 quarters.

Despite the company’s optimistic spin, the Bubs share price fell 8.7% over the 3 sessions following the trading update’s release.

The company also announced a new addition to its board last month.

Intellectual property, brand, and consumer lawyer Katrina Rathie has been appointed to Bubs’ board. Rathie’s appointment means the board is now gender-balanced.

Bubs share price snapshot

It’s not only been a bad month on the ASX for Bubs.

Bubs’ shares have fallen 31% year to date. They’re also trading for 54% less than they were this time last year.

The company has a market capitalisation of around $257 million, with approximately 612 million shares outstanding.

The post The Bubs (ASX:BUB) share price has fallen 17% in a month. Here’s why appeared first on The Motley Fool Australia.

More reading

• The Digital Wine (ASX:DW8) share price storms 8% higher
• Amazon investors are getting its e-commerce business for free
• Amazon stock: Investors expect too much
• 1 thing the market got wrong in Amazon’s earnings report
• Amazon investors get a reality check

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. 

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Amazon. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended the following options: long January 2022 $1,920 calls on Amazon and short January 2022 $1,940 calls on Amazon. The Motley Fool Australia has recommended Amazon and BUBS AUST FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3CBzF2C

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is fighting hard to stay in positive territory. At the time of writing, the benchmark index is up slightly to 7,541.9 points.

Four ASX shares that are climbing more than most today are listed below. Here’s why they are racing higher:

BlueBet Holdings Ltd (ASX: BBT)

The BlueBet share price is up 6.5% to $2.03. Investors have been buying the sports betting company’s shares after it signed an exclusive agreement with the Colorado River Indian Tribes (CRIT) and its wholly-owned subsidiary, BlueWater Resort and Casino. The agreement will see the parties pursue online sports betting market access in the state of Arizona.

James Hardie Industries plc (ASX: JHX)

The James Hardie share price is up 4% to $49.87. The catalyst for this was the release of a strong first quarter result from the building materials company. According to the release, James Hardie delivered a 35% increase in quarter sales over the prior corresponding period to US$843.3 million. And thanks to margin expansion, its net income was up 50% to US$134.2 million. This strong start to the year led to management upgrading full year net income guidance.

Megaport Ltd (ASX: MP1)

The Megaport share price has climbed almost 4% to $18.02. This follows the release of the network as a service (NaaS) solutions provider’s full year results. For the 12 months ended 30 June, Megaport reported a 35% increase in revenue to $78.28 million. Also growing strongly was its monthly recurring revenue (MRR), which increased 32% year on year to $7.5 million. This annualises to $90 million. Megaport also announced the US$15 million acquisition of InnovoEdge. It is an AI-powered multi-cloud and edge application orchestration company.

Novonix Ltd (ASX: NVX)

The Novonix share price has jumped 16.5% to $3.52. Investors have been fighting to get hold of the lithium-ion battery tech company’s shares after United States energy giant Phillips 66 made a strategic investment in the company. Phillips 66 will have a 16% stake in the company following the transaction.

The post Why BlueBet, James Hardie, Megaport, & Novonix shares are racing higher appeared first on The Motley Fool Australia.

More reading

• ASX 200 midday update: James Hardie hits record high, Pilbara Minerals rockets
• Why the PointsBet share price is up 6% on Tuesday
• Megaport (ASX:MP1) share price lifts after acquisition update
• Why the Novonix (ASX:NVX) share price is rocketing 11% out of a trading halt
• Up 8%, the BlueBet (ASX:BBT) share price is booming on Tuesday. Here’s why

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended MEGAPORT FPO. The Motley Fool Australia has recommended MEGAPORT FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/2VEk6Gz

The EMvision Medical Devices Ltd (ASX: EMV) share price is charging higher today. This follows the company providing an update in regard to its portable medical imaging technology.

At the time of writing, shares in the medical device company are 14.07% higher to $3 apiece. However, earlier in trade the EMvision share price had been as high as $3.10.

Milestone achievement

Investors are excited about the potential for EMvision today after the company announced the latest development of its brain scanner. After working on prototyping and development of its portable medical technology, today EMvision has notched up an achievement.

According to the release, the company has successfully fabricated and assembled its alpha unit of its first-generation portable brain scanner. These units are intended for commercialisation, giving shareholders hopes for future sales.

However, before we get ahead of ourselves… the first-gen units will be the subjects of a range of tests for assessing compliance with regulatory standards. These include:

• Functional compliance,
• Reliability compliance,
• Integration (software and hardware) compliance,
• Safety compliance, and
• Performance compliance

In addition to the above-noted compliance tests, the units will also be assessed on suitability for manufacturing, assembly, shipment, environmental impact, use, service, and repair.

Furthermore, the intended use of portable brain scanners is in applications where conventional neuroimaging machines are not accessible or practical.

For example, co-chair of the Australian Stoke Alliance, Professor Stephen Davis AO mentioned the possibility of such technology being incorporated into standard ambulances and aircraft. This potential has fed into the excitement surrounding the EMvision share price.

Management commentary

Speaking on the monumental step, EMvision CEO Dr Ron Weinberger said:

This is an important milestone for the Company. Our product represents a game-changing opportunity to provide accessible point-of-care neuroimaging for stroke patients, wherever they are. The value proposition for our scanner is simple – portable, accessible, fast, safe, and affordable.

We are tackling the immense health burden that is stroke, with potential future adjacencies in traumatic brain injury and other neurological disorders. We see an enormous market opportunity ahead in neuroimaging that is poised for disruption. Our device will undergo various tests as we prepare for our next stage of expanded clinical studies.

EMvision share price recap

The EMvision share price has delivered an exceptional return to shareholders over the past year. This is despite bottom-line losses deepening as it continues to invest heavily in research and development. Specifically, over the course of the year, shares in the company have surged nearly 60%. Meanwhile, the S&P/ASX 200 Index (ASX: XJO) has returned 23.4% during that time.

Finally, based on the current EMvision share price, the company holds a $216 million market capitalisation.

The post EMvision (ASX:EMV) share price leaps 14% on product update appeared first on The Motley Fool Australia.

More reading

• Is now a good time to buy Bendigo and Adelaide Bank (ASX:BEN) shares?
• Why is this fund holding onto its Afterpay (ASX:APT) shares?
• Why the Mesoblast (ASX:MSB) share price is edging higher on Tuesday
• Reckon (ASX:RKN) share price jumps 8% after strong first half profit growth
• Why the Aussie Broadband (ASX:ABB) share price just hit a new all-time high

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended EMvision Medical Devices Limited. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3jHe948

The Bendigo and Adelaide Bank Ltd (ASX: BEN) share price is having a pretty decent start to this Tuesday’s trading today. At the time of writing, Bendigo and Adelaide Bank shares are up a healthy 0.56% to $10.76 a share.

That puts this ASX bank’s 2021 gains so far at 13.86% year to date. It’s also up by a very pleasing 56.85% over the past 12 months, but a far more modest 2.57% over the past 5 years.

Wondering how that compares to the other ASX banks? Well, not quite as well as some. Commonwealth Bank of Australia (ASX: CBA) is presently up 26.3% year to date in 2021 so far, 43% over the past 12 months and 39% over the past 5 years.

But Bendigo Bank has certainly outperformed others. National Australia Bank Ltd (ASX: NAB) is up 17.77% year to date, 54.67% over the past 12 months and just 0.2% over the past 5 years.

Westpac Banking Corp (ASX: WBC) is up 30% year to date, 47.4% over the past year and has actually gone backwards by a hefty 13.8% over the past 5 years.

So with Bendigo Bank reporting its FY2021 earnings next Monday, many ASX investors might be wondering today if now is a good time to buy Bendigo and Adelaide Bank shares?

Are Bendigo Bank shares a buy today?

Well, one broker who thinks it might be a good time to keep one’s powder dry with Bendigo Bank right now is investment bank Goldman Sachs. Goldman currently rates Bendigo Bank shares as ‘neutral’ with a 12-month share price target of $10.75 a share.

You might notice that this is very similar to Bendigo Bank’s current share price — implying not too much in the way of potential upside (aside from dividend returns) over the next 12 months.

Goldman is lukewarm on Bendigo partly because the bank “has historically underperformed on costs” which, Goldman points out, have grown at a much faster rate than other ASX banks over the past few years.

Goldman also expects Bendigo to grow its earnings per share (EPS) at a modest rate over the next few years, forecasting EPS to rise from 71 cents per share in FY21 to 80 cents per share by FY2023.

It also expects Bendigo’s annual dividend to rise from 50 cents per share for FY21 to 60 cents per share by FY2023.

At the current Bendigo and Adelaide Bank share price, the company has a market capitalisation of $5.88 billion, a price-to-earnings (P/E) ratio of 22.9 and a trailing dividend yield of 2.6%.

The post Is now a good time to buy Bendigo and Adelaide Bank (ASX:BEN) shares? appeared first on The Motley Fool Australia.

More reading

• Top broker gives its verdict on the Westpac (ASX:WBC) share price
• How did the CBA (ASX:CBA) share price respond last earnings season?
• Why the CBA (ASX:CBA) share price will be on watch today
• Is the NAB (ASX:NAB) share price in the buy zone after its Citi acquisition?
• Is the Westpac (ASX:WBC) share price good value right now?

Motley Fool contributor Sebastian Bowen owns shares of National Australia Bank Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3izCZUg